SCHEMBL25720247

SCHEMBL25720247

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3cc(-c5cccc6oc7ccc(-n8c9ccccc9c9ccccc98)cc7c56)ccc34)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 1/20 0.35
PRKDC P78527 1/20 0.34
ALOX5 P09917 1/20 0.33
HCRTR1 O43613 1/20 0.33
KDM4E B2RXH2 3/20 0.32
ATM Q13315 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
AHR P35869 1/20 0.32
BACE1 P56817 1/20 0.31
CHEK2 O96017 1/20 0.31
ALDH1A1 P00352 3/20 0.31
HPGD P15428 3/20 0.31
MAPT P10636 2/20 0.31
TSHR P16473 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
TP53 P04637 1/20 0.30
NFKB1 P19838 1/20 0.30
MAPK1 P28482 1/20 0.30
NFKB2 Q00653 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25459681 1.00 PTGER4 (0.35) PTGER4PRKDCALOX5HCRTR1KDM4E
SCHEMBL25926537 0.98 PTGER4 (0.34) PTGER4PRKDCALOX5HCRTR1KDM4E
SCHEMBL25703380 0.98 PTGER4 (0.34) PTGER4PRKDCALOX5HCRTR1KDM4E
SCHEMBL24232640 0.98 PTGER4 (0.34) PTGER4PRKDCALOX5HCRTR1KDM4E
SCHEMBL23058092 0.97 PTGER4 (0.33) PTGER4PRKDCALOX5HCRTR1KDM4E
SCHEMBL25926553 0.97 PTGER4 (0.34) PTGER4PRKDCALOX5HCRTR1KDM4E
SCHEMBL25926684 0.97 PTGER4 (0.36) PTGER4PRKDCALOX5HCRTR1KDM4E
SCHEMBL25926795 0.96 BACE1 (0.32) PTGER4PRKDCALOX5HCRTR1KDM4E
SCHEMBL24217362 0.96 PTGER4 (0.35) PTGER4PRKDCALOX5HCRTR1KDM4E
SCHEMBL25458858 0.95 PLA2G2A (0.33) PTGER4PRKDCALOX5HCRTR1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed
EP-4190779-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT Materials Co., Ltd. (KR) 2023-06-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE CRY1, PPOX, ORC3 PTGER4 2825/4885PRKDC 3471/4885ALOX5 959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.